Warning letter
Vita-Herb Nutriceuticals, Inc. [ARCHIVED]: warning letter of Oct 20, 2010
FDA warning letter 126011 · Los Angeles District Office
Key facts
| Reference number | 126011 |
|---|---|
| Company | Vita-Herb Nutriceuticals, Inc. [ARCHIVED] |
| Subject | CGMP For Manufacturing, Packing, Labeling, or Holding for Dietary Supplements/Adulterated |
| Issue date | Oct 20, 2010 |
| Posted date | Oct 20, 2010 |
| Issuing office | Los Angeles District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.140(b)(3)(vi), 111.73, 111.260, 111.70(e), 111.140(b)(3), 111.140(b)(3)(i), 111.140(b)(3)(ii), 111.140(b)(3)(v), 111.75(c) |
| Inspection city | Placentia |
| Inspection ZIP | 92870 |
| Inspection start date | May 18, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: